BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35440301)

  • 1. New Trends in Nontransplant Therapy for Acquired Aplastic Anemia.
    Ding S; Fu R
    Curr Pharm Des; 2022; 28(21):1730-1737. PubMed ID: 35440301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic choices in immune aplastic anemia.
    Scheinberg P
    F1000Res; 2020; 9():. PubMed ID: 32953089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.
    Suzuki K; Muramatsu H; Okuno Y; Narita A; Hama A; Takahashi Y; Yoshida M; Horikoshi Y; Watanabe K; Kudo K; Kojima S
    Int J Hematol; 2016 Jul; 104(1):130-3. PubMed ID: 27107757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre.
    Shen Y; Li Y; Liu Q; Liu W; Yu Q; Hu H; Liu S; Dong J; Xu M; Hong Y; Chen Y; Deng S; Zhuang H; Hu Z; Lin S; Shen Y; Shen J; Zhou Y; Ye B; Wu D
    Ann Med; 2023; 55(2):2271475. PubMed ID: 37871262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going.
    Risitano AM
    Br J Haematol; 2011 Jan; 152(2):127-40. PubMed ID: 21118194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children.
    Yagasaki H; Shichino H; Ohara A; Kobayashi R; Yabe H; Ohga S; Hamamoto K; Ohtsuka Y; Shimada H; Inoue M; Muramatsu H; Takahashi Y; Kojima S
    Ann Hematol; 2014 May; 93(5):747-52. PubMed ID: 24337487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in medical therapy in aplastic anemia: why it took so long?
    Scheinberg P
    Int J Hematol; 2024 Mar; 119(3):248-254. PubMed ID: 38403842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.
    Iftikhar R; Chaudhry QUN; Anwer F; Neupane K; Rafae A; Mahmood SK; Ghafoor T; Shahbaz N; Khan MA; Khattak TA; Shamshad GU; Rehman J; Farhan M; Khan M; Ansar I; Ashraf R; Marsh J; Satti TM; Ahmed P
    Blood Rev; 2021 May; 47():100772. PubMed ID: 33187812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study.
    Shen Y; Liu Q; Li H; Liu W; Hu H; Zhao Y; Li Y; Chen Y; Liu S; Yu Q; Zhuang H; Wu L; Hu Z; Zheng Z; Shen J; Lin S; Shen Y; Zhou Y; Ye B; Wu D
    Ann Hematol; 2023 Mar; 102(3):503-517. PubMed ID: 36622392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment outcomes of 125 children with aplastic anemia].
    Luo CJ; Chen J; Xue HL; Tang JY; Pan C; Jiang H; Dong L; Luo CY; Ye QD; Zhou M; Gu LJ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):531-5. PubMed ID: 21122332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP).
    Barone A; Lucarelli A; Onofrillo D; Verzegnassi F; Bonanomi S; Cesaro S; Fioredda F; Iori AP; Ladogana S; Locasciulli A; Longoni D; Lanciotti M; Macaluso A; Mandaglio R; Marra N; Martire B; Maruzzi M; Menna G; Notarangelo LD; Palazzi G; Pillon M; Ramenghi U; Russo G; Svahn J; Timeus F; Tucci F; Cugno C; Zecca M; Farruggia P; Dufour C; Saracco P;
    Blood Cells Mol Dis; 2015 Jun; 55(1):40-7. PubMed ID: 25976466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
    Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
    Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.
    Kamio T; Ito E; Ohara A; Kosaka Y; Tsuchida M; Yagasaki H; Mugishima H; Yabe H; Morimoto A; Ohga S; Muramatsu H; Hama A; Kaneko T; Nagasawa M; Kikuta A; Osugi Y; Bessho F; Nakahata T; Tsukimoto I; Kojima S;
    Haematologica; 2011 Jun; 96(6):814-9. PubMed ID: 21422115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eltrombopag in Combination with Rabbit Anti-thymocyte Globulin/Cyclosporine A in Immunosuppressive Therapy-naïve Patients with Aplastic Anemia in Japan.
    Imada K; Obara N; Iida H; Imajo K; Maeda T; Usuki K; Fanghong Z; Hombo Y; Tajima T; Kumagai A; Matsuda A; Nakao S
    Intern Med; 2021 Apr; 60(8):1159-1168. PubMed ID: 33229810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response To Immunosuppressive Therapy In Patients Of Acquired Aplastic Anaemia: A Single Center Experience From A Developing Country.
    Khan M; Iftikhar R; Chaudhry QU; Mehmood SK; Faraz T; Ghafoor T; Shahbaz N; Khan MA; Shamshad GU; Khattak TA
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S969-S973. PubMed ID: 36550655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aplastic anemia: immunosuppressive therapy in 2010.
    Risitano AM; Perna F
    Pediatr Rep; 2011 Jun; 3 Suppl 2(Suppl 2):e7. PubMed ID: 22053283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
    Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
    Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcome of 301 aplastic anemia patients in China: a 10-year follow-up and real-world data from single institute experience.
    Zhang XT; Wang X; Cao J; Chen W; Qi KM; Qi N; Liang F; Dong XY; Tang GF; Li DP; Sang W; Li ZY; Cheng H; Xu KL
    Hematology; 2021 Dec; 26(1):1025-1030. PubMed ID: 34895103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired aplastic anemia in childhood.
    Guinan EC
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):171-91. PubMed ID: 19327578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.